GAAP Gene - Golgi Anti-Apoptotic Protein

GAAP Gene - Golgi Anti-Apoptotic Protein

<div class="infobox infobox-gene">
<h3>GAAP</h3>
<table>
<tr><th>Full Name</th><td>Golgi Anti-Apoptotic Protein</td></tr>
<tr><th>Gene Symbol</th><td>GAAP</td></tr>
<tr><th>Chromosomal Location</th><td>15q25.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[127653](https://www.ncbi.nlm.nih.gov/gene/127653)</td></tr>
<tr><th>OMIM</th><td>[618084](https://www.omim.org/entry/618084)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000149691</td></tr>
<tr><th>UniProt</th><td>[Q7RTV0](https://www.uniprot.org/uniprot/Q7RTV0)</td></tr>
<tr><th>Protein Length</th><td>347 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Introduction

The GAAP (Golgi Anti-Apoptotic Protein) gene, also known as TMEM135 (Transmembrane Protein 135), encodes a multifunctional membrane protein localized primarily to the Golgi apparatus and mitochondria. GAAP functions as a critical regulator of calcium homeostasis and cell survival, making it a significant player in neurodegenerative processes where calcium dysregulation and apoptotic cell death are central features[@liu2013][@gerasimenko2014].

GAAP Gene - Golgi Anti-Apoptotic Protein

<div class="infobox infobox-gene">
<h3>GAAP</h3>
<table>
<tr><th>Full Name</th><td>Golgi Anti-Apoptotic Protein</td></tr>
<tr><th>Gene Symbol</th><td>GAAP</td></tr>
<tr><th>Chromosomal Location</th><td>15q25.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[127653](https://www.ncbi.nlm.nih.gov/gene/127653)</td></tr>
<tr><th>OMIM</th><td>[618084](https://www.omim.org/entry/618084)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000149691</td></tr>
<tr><th>UniProt</th><td>[Q7RTV0](https://www.uniprot.org/uniprot/Q7RTV0)</td></tr>
<tr><th>Protein Length</th><td>347 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Introduction

The GAAP (Golgi Anti-Apoptotic Protein) gene, also known as TMEM135 (Transmembrane Protein 135), encodes a multifunctional membrane protein localized primarily to the Golgi apparatus and mitochondria. GAAP functions as a critical regulator of calcium homeostasis and cell survival, making it a significant player in neurodegenerative processes where calcium dysregulation and apoptotic cell death are central features[@liu2013][@gerasimenko2014].

First characterized for its anti-apoptotic properties, GAAP has emerged as an important regulator of cellular calcium handling, mitochondrial function, and stress responses. Its dual localization to both the Golgi apparatus and mitochondria positions it uniquely to modulate calcium signaling across cellular compartments. In the brain, GAAP is expressed in neurons and glia, where it helps maintain calcium homeostasis and protects against various forms of cellular stress that contribute to neurodegeneration.

GAAP is a 347-amino acid multipass membrane protein that serves multiple cellular functions. Its discovery as a Golgi-resident protein with anti-apoptotic activity established it as an important component of the cellular survival machinery. Subsequent research revealed its role as a calcium channel that regulates calcium flux between cellular compartments[@liu2013].

The protein's structure includes multiple transmembrane domains that facilitate its function as an ion channel. GAAP localizes to the Golgi apparatus, where it regulates calcium storage and release, and to mitochondria, where it influences mitochondrial calcium levels and the mitochondrial permeability transition pore (mPTP)[@chidsey2018].

--- [@liu2013]
title: GAAP is a Golgi-resident calcium channel that regulates apoptosis [@gerasimenko2014]
title: GAAP promotes cell survival by preventing mitochondrial permeability transition

:: infobox .infobox-gene
| Gene Symbol | GAAP |
| Alternative Names | TMEM135, HCA67 |
| Full Name | Golgi Anti-Apoptotic Protein |
| Chromosomal Location | 15q25.1 |
| NCBI Gene ID | [127653](https://www.ncbi.nlm.nih.gov/gene/127653) |
| UniProt | [Q7RTV0](https://www.uniprot.org/uniprot/Q7RTV0) |
| Protein Class | Multi-pass transmembrane protein |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Cancer](/diseases/cancer)
::

Molecular Function

Protein Structure

GAAP/TMEM135 is a multipass membrane protein:

| Feature | Details |
|---------|---------|
| Molecular weight | ~38 kDa |
| Structure | Multiple transmembrane domains |
| Subcellular localization | Golgi, mitochondria |
| Topology | Type III membrane protein |

Key structural features:

• Transmembrane domains: Six predicted transmembrane helices
• Calcium channel pore: Formed by transmembrane helices
• Golgi targeting signal: C-terminal retention signal
• Mitochondrial targeting: N-terminal signal sequence

Calcium Channel Activity

GAAP functions as a calcium leak channel[@taylor2016]:

Anti-Apoptotic Function

GAAP protects against cell death through multiple mechanisms[@gerasimenko2014][@yang2019]:

• mPTP inhibition: Prevents mitochondrial permeability transition
• Caspase inhibition: Blocks activation of apoptotic caspases
• Bcl-2 modulation: Regulates Bcl-2 family protein function
• ER stress protection: Reduces ER stress-induced apoptosis

Gene Structure and Protein Architecture

Genomic Organization

The GAAP/TMEM135 gene spans approximately 23 kb on chromosome 15q25.1 and consists of 15 exons encoding a 347-amino acid protein. The gene is conserved across mammalian species, reflecting its essential cellular functions.

Protein Topology

GAAP is a multi-pass transmembrane protein with distinctive structural features:

| Feature | Description |
|---------|-------------|
| Transmembrane domains | 6 predicted α-helical transmembrane segments |
| N-terminal region | Cytoplasmic, contains potential regulatory motifs |
| Loop regions | Form luminal/cytoplasmic domains with functional sites |
| C-terminal tail | Cytoplasmic, involved in protein interactions |

Subcellular Localization

GAAP exhibits dynamic subcellular distribution:

Calcium Homeostasis Regulation

GAAP serves as a crucial regulator of intracellular calcium dynamics:

1. Calcium Leak Channel Function

• GAAP forms calcium-permeable channels in the ER membrane
• Promotes basal calcium leak from ER stores
• Prevents excessive calcium accumulation in ER lumen
• Maintains optimal cytosolic calcium levels

2. Mitochondrial Calcium Handling

• Regulates mitochondrial calcium uptake
• Modulates mitochondrial calcium efflux pathways
• Protects against mitochondrial calcium overload
• Couples cytosolic calcium signals to metabolic responses

3. Store-Operated Calcium Entry

• Influences SOCE (Store-Operated Calcium Entry) machinery
• Modulates STIM1-Orai1 interactions
• Affects calcium influx upon ER depletion

Metabolic Regulation

GAAP influences cellular energetics:

| Function | Mechanism | Neuronal Relevance |
|----------|-----------|-------------------|
| Mitochondrial respiration | Modulates complex I/IV activity | Energy production for synaptic function |
| ATP production | Coupling of calcium to metabolism | Neuronal survival under stress |
| Glycolysis regulation | Indirect effects via calcium | Metabolic adaptation |
| ROS production | Mitochondrial calcium handling | Oxidative stress response |

Membrane Contact Site Regulation

GAAP functions at membrane contact sites:

ER-Mitochondria Tethering

• GAAP localizes to ER-mitochondria contact sites (ERMCS)
• Modulates mitochondrial calcium transfer
• Influences lipid exchange between organelles
• Affects autophagosome formation

• Golgi-derived vesicles influence mitochondrial function
• GAAP coordinates this communication
• Affects mitochondrial quality control

Expression Patterns

Tissue Distribution

GAAP is expressed across multiple tissues with highest levels in:

• Brain: Neurons and glia throughout the CNS
• Heart: Cardiomyocytes
• Liver: Hepatocytes
• Kidney: Tubular cells

Brain Expression

In the central nervous system, GAAP is expressed in:

• Neurons: Both excitatory and inhibitory populations
• Astrocytes: Supporting cellular homeostasis
• Microglia: Modulating inflammatory responses
• Oligodendrocytes: Supporting myelination

Developmental Regulation

GAAP expression changes during development:

• Higher expression in embryonic brain
• Decreases during early postnatal development
• Maintained at moderate levels in adult brain
• Altered expression in disease states

Role in Neurodegeneration

Calcium Dysregulation in Neurodegeneration

Calcium dysregulation is a hallmark of neurodegenerative diseases, and GAAP's function makes it particularly relevant:

Common Mechanisms:

GAAP's calcium channel and buffer functions could theoretically counteract these dysregulations.

Alzheimer's Disease

GAAP/TMEM135 has several connections to AD pathogenesis:

1. Amyloid-Beta Toxicity

• Aβ exposure alters GAAP expression in neurons
• GAAP dysfunction may sensitize neurons to Aβ toxicity
• Calcium dysregulation by Aβ may override GAAP protection

• Tau accumulation affects mitochondrial calcium handling
• GAAP expression correlates with tau burden
• May influence tau-induced synaptic dysfunction

• Calcium dysregulation underlies synaptic loss
• GAAP maintains synaptic calcium homeostasis
• Protects against synaptic apoptosis

Parkinson's Disease

In PD, GAAP has several relevant functions:

1. Mitochondrial Dysfunction

• PD involves prominent mitochondrial defects
• GAAP regulates mitochondrial calcium and function
• May protect against dopaminergic neuron death

• GAAP expression altered by α-synuclein aggregation
• Calcium dysregulation precedes neuronal death
• GAAP could modulate this pathway

• MPTP and other PD toxins affect calcium handling
• GAAP may counteract toxin-induced dysregulation

Other Neurodegenerative Diseases

The protein is also implicated in other conditions:

• Amyotrophic lateral sclerosis: Calcium dysregulation in motor neurons
• Huntington's disease: Mutant huntingtin disrupts calcium homeostasis
• Multiple sclerosis: Calcium dysregulation in glial cells

Molecular Interactions

Protein-Protein Interactions

| Partner | Interaction Type | Functional Outcome |
|---------|-------------------|-------------------|
| Bcl-2 | Direct binding | Anti-apoptotic synergy |
| Bcl-XL | Direct binding | Anti-apoptotic synergy |
| VDAC1 | Mitochondrial localization | Calcium transport |
| STIM1 | SOCE modulation | Calcium influx |
| Calmodulin | Calcium-dependent | Regulatory binding |
| IRE1 | ER stress pathways | UPR modulation |

Signaling Pathways

GAAP influences multiple signaling cascades:

• Calcium signaling: Calmodulin-dependent pathways
• Apoptosis: Intrinsic (mitochondrial) pathway
• ER stress: IRE1/XBP1 and PERK/ATF4 pathways
• mTOR signaling: Metabolic regulation

Therapeutic Implications

Targeting GAAP in Neurodegeneration

Therapeutic strategies involving GAAP:

--- [@wang2021]
title: Small molecule modulators of GAAP for neuroprotection [@park2020]
title: GAAP gene therapy in mouse models of neurodegeneration

Biomarker Potential

GAAP has potential as:

• Diagnostic marker: Peripheral blood cell expression
• Disease progression: Correlation with severity
• Therapeutic target: Direct modulation

Challenges

Key challenges remain:

Related Pathways

• [Calcium signaling](/mechanisms/calcium-signaling) — Central to GAAP function
• [Apoptosis pathway](/mechanisms/apoptosis) — GAAP inhibits this pathway
• [Mitochondrial dynamics](/mechanisms/mitochondrial-dynamics) — GAAP modulates mitochondrial function
• [ER stress response](/mechanisms/er-stress-pathway) — GAAP provides protection
• [ER-mitochondria contact sites](/mechanisms/er-mitochondria-tethering) — GAAP localizes here

Related Proteins

• [SNCA](/genes/snca) — alpha-synuclein, PD-linked
• [PARK2 (Parkin)](/genes/parkin) — mitochondrial E3 ubiquitin ligase
• [PINK1](/genes/pink1) — mitochondrial kinase
• [CALM1](/genes/calm1) — calmodulin
• [VDAC1](/genes/vdac1) — voltage-dependent anion channel

Research Directions

Key questions remain:

Cross-Links

• [TMEM135 Protein](/proteins/tmem135-protein) — Protein-focused page
• [Calcium Signaling Pathway](/mechanisms/calcium-signaling) — Mechanism
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease association
• [Parkinson's Disease](/diseases/parkinsons-disease) — Disease association
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) — Mechanism
• [ER Stress in Neurodegeneration](/mechanisms/er-stress-pathway) — Mechanism

References